The activation impact of lactobacillus-derived extracellular vesicles on lipopolysaccharide-induced microglial cell

Yanfang Yang1, Na Li1, Yubo Gao1

  • 1Department of Anaesthesia and Perioperative Medicine, General Hospital of Ningxia Medical University, Yinchuan, 750004, China.

BMC Microbiology
|February 28, 2024
PubMed

Insights

Lactobacillus extracellular vesicles (Lac-EVs) reduce neuroinflammation and promote beneficial M2 microglial polarization, offering a potential strategy for preventing inflammation-related perioperative neurocognitive dysfunction (PND) in elderly patients.

Area of Science:

  • Neuroscience
  • Immunology
  • Microbiology

Background:

  • Perioperative neurocognitive dysfunction (PND) is a common postoperative complication in elderly patients.
  • Neuroinflammation, potentially linked to gut microbiota alterations, is implicated in PND pathogenesis.
  • Lactobacillus (Lac) probiotics and their extracellular vesicles (EVs) show potential for modulating CNS functions.

Purpose of the Study:

  • To investigate the therapeutic potential of Lac-EVs in an in vitro neuroinflammation model of PND.
  • To determine the effect of Lac-EVs on microglial (MG) polarization and inflammatory responses.

Main Methods:

  • Established an in vitro neuroinflammation model using lipopolysaccharide (LPS) to mimic PND.
  • Treated the model with Lactobacillus extracellular vesicles (Lac-EVs).
  • Assessed microglial polarization (M1/M2 markers, iNOS, Arg1), inflammatory cytokine secretion (IL-1β, IL-6, IL-10), and cellular viability.

Main Results:

  • Lac-EVs reduced LPS-induced inflammation in microglia, decreasing M1 marker (iNOS) and increasing M2 marker (Arg1) mRNA expression.
  • Lac-EVs shifted microglial polarization towards the M2 phenotype, as confirmed by flow cytometry.
  • Lac-EVs suppressed pro-inflammatory cytokines (IL-1β, IL-6) and enhanced anti-inflammatory cytokine (IL-10) production.

Conclusions:

  • Lac-EVs promote M2 microglial activation and exhibit anti-inflammatory effects in vitro without causing cellular harm.
  • Lac-EVs represent a promising therapeutic strategy for mitigating inflammation-driven perioperative neurocognitive dysfunction.